Heat Biologics, Inc

(NASDAQ:HTBX)

Latest On Heat Biologics, Inc (HTBX):

Date/Time Type Description Signal Details
2022-05-03 14:57 ESTNewsHeat Biologics completes name change to NightHawk BiosciencesN/A
2022-04-27 23:26 ESTNewsHeat Biologics stock soars 9% on supply contract with Canada for anthrax drug AnthimN/A
2022-04-19 23:37 ESTNewsHeat Biologics to rebrand as NightHawk Biosciences from next monthN/A
2022-04-18 16:10 ESTNewsHeat Biologics’ unit Scorpion, Kansas state to develop biodefense-focused manufacturing facilityN/A
2022-03-14 11:49 ESTNewsHeat Biologics reports 2021 revenue $2.1M, consensus $2.11MN/A
2022-02-02 19:46 ESTNewsHeat Biologics to move to NYSE from NasdaqN/A
2022-01-31 18:05 ESTNewsHeat Biologics rises 10% as Elusys finalizes HHS contract for anthrax antitoxin AnthimN/A
2022-01-29 01:29 ESTNewsHeat Biologics (HTBX) Investor Presentation - SlideshowN/A
2021-12-21 22:22 ESTNewsHeat Biologics to acquire biodefense company, Elusys TherapeuticsN/A
2021-12-01 02:47 ESTNewsHeat Bio unveils RapidVax vaccine platform targeting emerging biological threatsN/A
2021-11-11 07:11 ESTNewsHeat Biologics EPS in-line, beats on revenueN/A
2021-08-26 14:16 ESTNewsHeat Biologics launches Skunkworx Bio, new drug discovery subsidiaryN/A
2021-08-25 18:36 ESTNewsHeat Biologics taps former U.S. Senator seeking to advance new biothreat programsN/A
2021-08-11 22:01 ESTNewsHeat Biologics EPS beats by $0.05, misses on revenueN/A
2021-07-21 11:29 ESTNewsHeat Biologics records biggest one-day gain in over four monthsN/A
2021-07-21 11:18 ESTNewsHeat Biologics expands R&D and pre-clinical capabilitiesN/A
2021-07-21 11:17 ESTNewsHeat Biologics added to Russell Microcap IndexN/A
2021-05-05 17:30 ESTNewsHeat Biologics EPS misses by $0.01, misses on revenueN/A
2021-03-26 10:24 ESTNewsTLRY, GLUU, ABEO and TYME among premarket gainersN/A
2021-03-05 15:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $29.25 to $27.8.Neutral
2021-03-04 03:30 ESTNewsHeat Biologics shares surge 17% premarket as Cantor initiates with overweight ratingN/A
2021-02-11 03:53 ESTAnalyst RatingThe Analyst Target Price has increased from $28 to $29.25.Buy
2021-02-10 12:44 ESTNewsHeat Biologics' shares take off after HS-110-OPDIVO combo shines in mid-stage trialN/A
2021-01-27 16:29 ESTNewsHeat Biologics is down after announcing publication of COVID-19 vaccine dataN/A
2021-01-27 00:48 ESTNewsHeat Biologics hires advisory firm to support government collaborationsN/A
2021-01-25 03:04 ESTNewsHeat Biologics: Investors Would Be Wise To Hold Off Until 2H 2021 Clinical Trial Interim ResultsN/A
2021-01-24 23:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.25 to $28.Neutral
2021-01-06 21:34 ESTNewsHeat Biologics signs a licensing agreement; Appoints new CFON/A
2020-12-25 15:46 ESTAnalyst RatingThe Analyst Target Price has decreased from $33.25 to $31.25.Neutral
2020-12-17 04:03 ESTAnalyst RatingThe Analyst Target Price has increased from $4.75 to $33.25.Buy
2020-12-17 00:54 ESTNewsHeat Biologics soars 14% on completion of ZVX-60 vaccine cell line for COVID-19N/A
2020-12-12 04:03 ESTStock SplitA stock split has occured on Dec 11, 2020 with a split factor of 1:7.Neutral
2020-12-10 13:05 ESTNewsHeat Biologics announces reverse stock split dragging the sharesN/A
2020-11-26 20:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 20:17 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 12:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 04:07 ESTEarnings EstimateAn EPS average of -$0.04 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-09 10:35 ESTNewsHeat Biologics EPS misses by $0.03, beats on revenueN/A
2020-11-09 10:34 ESTNewsSecond tier COVID-19 vaccine developers under pressure on positive Pfizer/BioNTech dataN/A
2020-11-07 16:06 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 02:04 ESTNewsHeat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of BiopharmaN/A
2020-10-15 00:58 ESTAnalyst RatingThe Analyst Target Price has decreased from $5 to $4.75.Neutral
2020-10-07 19:47 ESTNewsHeat Biologics secures new patent related to gp96 platformN/A
2020-09-26 13:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:09 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 21:41 ESTNewsInovio (+27%) adds to corporate update-stoked rallyN/A
2020-09-09 21:48 ESTNewsCOVID-19 vaccine developers rally on AstraZeneca study pauseN/A
2020-09-02 16:37 ESTNewsHeat Biologics nabs new U.S. patent covering gp96 platformN/A
2020-08-25 10:23 ESTNewsAstraZeneca's COVID-19 competitors under pressure on reports co. may get early nod in U.S. for vaccineN/A
2020-08-23 03:00 ESTNewsInvestors in COVID-19 stocks face turmoil in coming weeks on vaccine data readoutsN/A

About Heat Biologics, Inc (HTBX):

Heat Biologics, Inc., a biopharmaceutical company, focuses on developing immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. The company's T-cell activation platform, includes two variations for intradermal administration, such as immune pan-antigen cytotoxic therapy, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and combination pan-antigen cytotoxic therapy, a dual-acting immunotherapy, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. It is developing HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer. The company's preclinical stage products include HS-130 for the treatment of advanced solid tumors; PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25 signaling; and PTX-45, a human TL1A-Ig fusion protein that acts as an agonist of TNFRSF25 signaling. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.

HTBX Quotes by TradingView

See Advanced Chart

General

  • Name Heat Biologics, Inc
  • Symbol HTBX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 36
  • Last Split Factor1:7
  • Last Split Date2020-12-11
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.heatbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 21.18
  • Price/Book (Most Recent Quarter) 1.5
  • Enterprise Value Revenue 15.39
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.04
  • Operating Margin -497%
  • Return on Assets -17%
  • Return on Equity -34%
  • Revenue 4.34 million
  • Earnings Per Share -$0.65
  • Revenue Per Share $0.38
  • Gross Profit -9964500
  • Quarterly Earnings Growth 13096.6%
View More

Highlights

  • Market Capitalization 199.11 million
  • EBITDA -20375828
  • Analyst Target Price $27.8
  • Book Value Per Share $5.42
View More

Share Statistics

  • Shares Outstanding 22.83 million
  • Shares Float 21.75 million
  • % Held by Insiders 301%
  • % Held by Institutions 12.27%
  • Shares Short 2.02 million
  • Shares Short Prior Month 2.03 million
  • Short Ratio 0.41
  • Short % of Float 9%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 0.18
  • 52 Week High $30.1
  • 52 Week Low $3.22
  • 50 Day Moving Average 8.68
  • 200 Day Moving Average 7.86
View More

Dividends

  • Dividend Date 2020-12-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Heat Biologics, Inc (HTBX) Dividend Calendar:

HTBX's last dividend payment was made to shareholders on December 11, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Heat Biologics, Inc (HTBX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$N/A-$0.42-$0.23-80.03%
2020-06-302020-08-07$N/A-$0.35-$0.4928.57%
2020-03-312020-05-15$901880-$0.77-$0.70-10%
2019-12-312020-03-30$N/A-$0.70-$1.0030.23%
2019-09-302019-11-14$6439-$1.26-$0.91-38.46%
2019-06-302019-08-14$342487-$0.98-$1.023.45%
2019-03-312019-05-15$701062-$1.19-$1.265.56%
2018-12-312019-03-28$2.06 million-$1.05-$1.1710%
2018-09-302018-11-14$1.84 million-$1.12-$1.142.04%
2018-06-302018-08-14$1.14 million-$1.89-$1.26-50%
2018-03-312018-05-15$752527-$5.25-$0.70-650%
2017-12-312018-03-02$614000-$2.27-$4.9053.61%
2017-09-302017-11-13$471000-$4.20-$6.3033.33%
2017-06-302017-08-14$411000-$6.30-$7.0010%
2017-03-312017-05-11$24000-$8.40-$10.5020%
2016-12-312017-03-31$122000-$8.40-$4.90-71.43%
2016-09-302016-11-10$220000-$5.60-$10.5046.67%
2016-06-302016-08-15$N/A-$11.90-$18.2034.62%
2016-03-312016-05-11$N/A-$35.00-$39.2010.71%
2015-12-312016-02-18$N/A-$54.60-$45.03-21.24%
2015-09-302015-10-30$N/A-$0.62-$0.61-1.64%
2015-06-302015-08-13$N/A-$0.56-$0.47-19.15%
2015-03-312015-05-14$N/A-$0.57-$0.49-16.33%
2014-12-312015-03-27$N/A-$0.56-$0.43-30.23%
2014-09-302014-11-14$N/A-$0.46-$0.41-12.2%
2014-06-302014-08-14$N/A-$0.44-$0.42-4.76%
2014-03-312014-04-01$N/A-$5.50-$3.00-83.33%
2013-12-312014-03-31$N/A-$5.50-$3.00-83.33%
2013-09-302013-11-14$N/A-$4.80-$2.25-113.33%
2013-06-302013-08-28$N/A-$18.31

Heat Biologics, Inc (HTBX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Heat Biologics, Inc (HTBX) Chart:

Heat Biologics, Inc (HTBX) News:

Below you will find a list of latest news for Heat Biologics, Inc (HTBX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Heat Biologics, Inc (HTBX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Heat Biologics, Inc (HTBX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000546/0001553350-20-000546-index.htm
2020-05-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1476963/000000000020003787/0000000000-20-003787-index.htm
2018-05-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000090266418002234/0000902664-18-002234-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000091957420000579/0000919574-20-000579-index.htm
2018-11-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000110465918070761/0001104659-18-070761-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000110465919008580/0001104659-19-008580-index.htm
2018-11-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000114420418062648/0001144204-18-062648-index.htm
2018-12-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000119312518341094/0001193125-18-341094-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000119312519040193/0001193125-19-040193-index.htm
2019-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000153561019000007/0001535610-19-000007-index.htm
2020-01-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1476963/000153561020000057/0001535610-20-000057-index.htm
2018-05-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018000475/0001553350-18-000475-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000494/0001553350-18-000494-index.htm
2018-05-14PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000537/0001553350-18-000537-index.htm
2018-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000541/0001553350-18-000541-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018000542/0001553350-18-000542-index.htm
2018-05-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000650/0001553350-18-000650-index.htm
2018-06-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000730/0001553350-18-000730-index.htm
2018-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000833/0001553350-18-000833-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000934/0001553350-18-000934-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018000935/0001553350-18-000935-index.htm
2018-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335018000975/0001553350-18-000975-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018001079/0001553350-18-001079-index.htm
2018-10-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1476963/000155335018001095/0001553350-18-001095-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018001239/0001553350-18-001239-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018001242/0001553350-18-001242-index.htm
2018-11-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018001279/0001553350-18-001279-index.htm
2018-11-21424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1476963/000155335018001287/0001553350-18-001287-index.htm
2018-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018001288/0001553350-18-001288-index.htm
2018-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335018001291/0001553350-18-001291-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000005/0001553350-19-000005-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000006/0001553350-19-000006-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000007/0001553350-19-000007-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000008/0001553350-19-000008-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000009/0001553350-19-000009-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000010/0001553350-19-000010-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000011/0001553350-19-000011-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000017/0001553350-19-000017-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000022/0001553350-19-000022-index.htm
2019-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000025/0001553350-19-000025-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000044/0001553350-19-000044-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000171/0001553350-19-000171-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000179/0001553350-19-000179-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000185/0001553350-19-000185-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000202/0001553350-19-000202-index.htm
2019-03-138-A12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000208/0001553350-19-000208-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000266/0001553350-19-000266-index.htm
2019-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000267/0001553350-19-000267-index.htm
2019-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000309/0001553350-19-000309-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000310/0001553350-19-000310-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000312/0001553350-19-000312-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000326/0001553350-19-000326-index.htm
2019-04-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000327/0001553350-19-000327-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000413/0001553350-19-000413-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000414/0001553350-19-000414-index.htm
2019-04-2410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000432/0001553350-19-000432-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000480/0001553350-19-000480-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000525/0001553350-19-000525-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000526/0001553350-19-000526-index.htm
2019-05-22PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000595/0001553350-19-000595-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000612/0001553350-19-000612-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000615/0001553350-19-000615-index.htm
2019-06-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000622/0001553350-19-000622-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000663/0001553350-19-000663-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000665/0001553350-19-000665-index.htm
2019-07-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000693/0001553350-19-000693-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000701/0001553350-19-000701-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000747/0001553350-19-000747-index.htm
2019-08-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000768/0001553350-19-000768-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000811/0001553350-19-000811-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335019000813/0001553350-19-000813-index.htm
2019-08-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000820/0001553350-19-000820-index.htm
2019-08-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000856/0001553350-19-000856-index.htm
2019-08-228-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000887/0001553350-19-000887-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019000994/0001553350-19-000994-index.htm
2019-09-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001010/0001553350-19-001010-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001011/0001553350-19-001011-index.htm
2019-10-04S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1476963/000155335019001031/0001553350-19-001031-index.htm
2019-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001070/0001553350-19-001070-index.htm
2019-10-18PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001071/0001553350-19-001071-index.htm
2019-10-25S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1476963/000155335019001090/0001553350-19-001090-index.htm
2019-11-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001109/0001553350-19-001109-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001123/0001553350-19-001123-index.htm
2019-11-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1476963/000155335019001125/0001553350-19-001125-index.htm
2019-11-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001133/0001553350-19-001133-index.htm
2019-11-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001135/0001553350-19-001135-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155335019001190/0001553350-19-001190-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001199/0001553350-19-001199-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001218/0001553350-19-001218-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001222/0001553350-19-001222-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001235/0001553350-19-001235-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335019001298/0001553350-19-001298-index.htm
2020-01-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000001/0001553350-20-000001-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000002/0001553350-20-000002-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000003/0001553350-20-000003-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000004/0001553350-20-000004-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000005/0001553350-20-000005-index.htm
2020-01-034/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000007/0001553350-20-000007-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000008/0001553350-20-000008-index.htm
2020-01-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000011/0001553350-20-000011-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000020/0001553350-20-000020-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000022/0001553350-20-000022-index.htm
2020-01-13PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000026/0001553350-20-000026-index.htm
2020-01-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1476963/000155335020000028/0001553350-20-000028-index.htm
2020-01-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000032/0001553350-20-000032-index.htm
2020-01-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000033/0001553350-20-000033-index.htm
2020-01-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000034/0001553350-20-000034-index.htm
2020-01-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000035/0001553350-20-000035-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000046/0001553350-20-000046-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000049/0001553350-20-000049-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000050/0001553350-20-000050-index.htm
2020-01-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000057/0001553350-20-000057-index.htm
2020-01-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000059/0001553350-20-000059-index.htm
2020-01-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000060/0001553350-20-000060-index.htm
2020-01-17424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1476963/000155335020000068/0001553350-20-000068-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000080/0001553350-20-000080-index.htm
2020-01-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000089/0001553350-20-000089-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000125/0001553350-20-000125-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000174/0001553350-20-000174-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000184/0001553350-20-000184-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000189/0001553350-20-000189-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000196/0001553350-20-000196-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000198/0001553350-20-000198-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000203/0001553350-20-000203-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000209/0001553350-20-000209-index.htm
2020-03-138-A12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1476963/000155335020000213/0001553350-20-000213-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000215/0001553350-20-000215-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000218/0001553350-20-000218-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000219/0001553350-20-000219-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000229/0001553350-20-000229-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000232/0001553350-20-000232-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000233/0001553350-20-000233-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000250/0001553350-20-000250-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1476963/000155335020000252/0001553350-20-000252-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000308/0001553350-20-000308-index.htm
2020-04-23S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1476963/000155335020000356/0001553350-20-000356-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000357/0001553350-20-000357-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000375/0001553350-20-000375-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000378/0001553350-20-000378-index.htm
2020-05-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000383/0001553350-20-000383-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000433/0001553350-20-000433-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000496/0001553350-20-000496-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000501/0001553350-20-000501-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000510/0001553350-20-000510-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000546/0001553350-20-000546-index.htm
2020-07-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000653/0001553350-20-000653-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000655/0001553350-20-000655-index.htm
2020-07-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1476963/000155335020000657/0001553350-20-000657-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000659/0001553350-20-000659-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000670/0001553350-20-000670-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000673/0001553350-20-000673-index.htm
2020-07-29DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000674/0001553350-20-000674-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000759/0001553350-20-000759-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000794/0001553350-20-000794-index.htm
2020-08-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1476963/000155335020000796/0001553350-20-000796-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000797/0001553350-20-000797-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000800/0001553350-20-000800-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155335020000956/0001553350-20-000956-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155837020006715/0001558370-20-006715-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155837020006725/0001558370-20-006725-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1476963/000155837020009804/0001558370-20-009804-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1476963/000155837020009805/0001558370-20-009805-index.htm
2020-10-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1476963/000155837020011458/0001558370-20-011458-index.htm
2018-05-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1476963/999999999518001102/9999999995-18-001102-index.htm
2020-01-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1476963/999999999520000098/9999999995-20-000098-index.htm
2020-05-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1476963/999999999520001026/9999999995-20-001026-index.htm

Heat Biologics, Inc (HTBX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heat Biologics, Inc (HTBX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 301%
Institutional Ownership: 1227%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-01-01Jeff Tobin HutchinsChief Scientific OfficerBuy143,140.00143,140.00https://www.sec.gov/Archives/edgar/data/1476963/000155335019000006/0001553350-19-000006-index.htm
2020-08-13William L. OstranderVP Finance/Corp SecyBuy15,625.000.528,125.0015,625.00https://www.sec.gov/Archives/edgar/data/1476963/000155335020000759/0001553350-20-000759-index.htm
2019-12-31Jeffrey Alan WolfChief Executive OfficerBuy900,000.001,788,693.00https://www.sec.gov/Archives/edgar/data/1476963/000155335020000002/0001553350-20-000002-index.htm
2019-01-01JOHN K A PRENDERGASTDirectorBuy300,000.00300,000.00https://www.sec.gov/Archives/edgar/data/1476963/000155335019000010/0001553350-19-000010-index.htm
2020-01-02Jeffrey Alan WolfChief Executive OfficerBuy1,980,000.003,768,693.00https://www.sec.gov/Archives/edgar/data/1476963/000155335020000002/0001553350-20-000002-index.htm
2020-01-02JOHN K A PRENDERGASTDirectorBuy400,000.00700,000.00https://www.sec.gov/Archives/edgar/data/1476963/000155335020000003/0001553350-20-000003-index.htm
2019-01-01Jeffrey Alan WolfChief Executive OfficerBuy800,000.00848,317.00https://www.sec.gov/Archives/edgar/data/1476963/000155335019000009/0001553350-19-000009-index.htm
2019-01-01Ann A RosarVP of FinanceBuy89,430.0093,379.00https://www.sec.gov/Archives/edgar/data/1476963/000155335019000008/0001553350-19-000008-index.htm